NF1 Mutation
·MeSH: Neurofibromatosis 1
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| pas-004 | Pasithea Therapeutics Corp. (KTTA) |
Frequently asked questions
How many drugs are in development for NF1 Mutation?
BioSniper tracks 1 drug in development for NF1 Mutation across 1 company.
How many clinical trials target NF1 Mutation?
There are 3 clinical trials targeting NF1 Mutation tracked by BioSniper.
Deep-dive into NF1 Mutation
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis